US Supreme Court Weighs Cancer Claims Against Roundup Weedkiller

John Durnell never expected his garden routine would lead to the US Supreme Court. The homeowner, awarded £1.25 million by a jury for claims that Roundup failed to warn him about cancer risks, now finds himself at the centre of a legal battle that could reshape how America regulates one of the world’s most widely used weedkillers.

On 27 April 2026, nine justices gathered in Washington to hear oral arguments in a case that extends far beyond one man’s lawsuit. The decision will determine whether Bayer – which acquired Roundup’s original maker Monsanto in 2018 – must face tens of thousands of similar claims alleging the glyphosate-based herbicide causes cancer without adequate warnings.

The Science Behind the Split

The legal fight stems from a fundamental disagreement between regulators. In 2015, the World Health Organization’s International Agency for Research on Cancer classified glyphosate as “probably carcinogenic to humans” – a designation that through the agricultural industry.

But the US Environmental Protection Agency has repeatedly pushed back. The EPA maintains glyphosate is “not likely to be carcinogenic to humans” when used as directed, approving product labels without cancer warnings. This regulatory divide has created the perfect storm for litigation.

Bayer has already set aside approximately £3.5 billion to settle existing Roundup lawsuits while continuing to deny the product causes cancer. The company argues that federal pesticide regulations should shield it from state failure-to-warn lawsuits, ensuring uniform national standards rather than a patchwork of conflicting requirements.

What’s at Stake

The core legal question isn’t whether glyphosate causes cancer – that scientific debate continues to rage. Instead, the justices must decide whether federal approval of a pesticide without cancer warnings prevents individual states from allowing failure-to-warn lawsuits.

Plaintiffs argue that state laws should permit warnings based on evolving research like the IARC findings, putting consumer safety ahead of federal preemption. They contend that farmers, gardeners, and groundskeepers deserve access to all available information about potential risks.

The stakes couldn’t be higher. A ruling in Bayer’s favour could effectively end the flood of Roundup litigation that has already resulted in multibillion-pound verdicts. But a decision favouring plaintiffs could open the floodgates to thousands more lawsuits, potentially forcing warning labels despite federal approval.

Key Takeaways

• The US Supreme Court heard arguments on 27 April 2026 that could determine whether Bayer faces tens of thousands more Roundup cancer lawsuits
• The case centres on whether federal pesticide approval prevents state failure-to-warn claims, not on whether glyphosate actually causes cancer
• Bayer has already reserved approximately £3.5 billion for Roundup litigation settlements while maintaining the product is safe

What This Means for Kent Residents

Glyphosate-based herbicides like Roundup remain widely available across Kent, used by farmers, gardeners, and local councils for weed control on everything from crop fields to roadside verges. While no specific Kent lawsuits have been identified, the Supreme Court’s ruling could influence global agrochemical regulation and potentially affect product labelling requirements in the UK. Kent residents using glyphosate products should continue following Health and Safety Executive-approved labels, though current UK and EU rules don’t require cancer warnings – for now, the regulatory landscape on both sides of the Atlantic continues to evolve as this landmark case unfolds.